Management of hypoglycaemia post- bariatric surgery

This is a Novo Nordisk Sponsored meeting

Novo Nordisk has provided sponsorship to the Association of British Clinical Diabetologists (ABCD) to fully fund all costs for the development and delivery of this webinar, including creation, administration, promotion and speaker honoraria. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ABCD.

Management of hypoglycaemia post- bariatric surgery

Tuesday 6th December 2022, 19.00 - 20.00

In this webinar join Professor Tricia Tan to discuss management of hypoglycaemia post- bariatric surgery. Bariatric or metabolic surgery is a proven treatment for durable weight loss, and offers the prospect of long-term remission of diabetes. Surgery is being increasingly considered for the treatment of obesity and diabetes and is becoming increasingly common. As a result, physicians are encountering complications arising from bariatric surgery in metabolic and diabetes clinics. One such complication is post-bariatric hypoglycaemia, typically a hyperinsulinaemic hypoglycaemia which occurs between 1-3 hours after ingestion of food. Far from being a rare complication, recent studies demonstrate that hypoglycaemia after bariatric surgery may be very common. In this talk, Dr Tan will discuss the aetiopathogenesis of post-bariatric hypoglycaemia, implications for patient health and its management.

Join us on the 6th December for the live Q & A panel discussion

This webinar is for UK Healthcare Professionals only

Speakers

Professor Rob Andrews

Rob Andrews is an Associate Professor at the University of Exeter, an Honorary Consultant Physician at Musgrove Park Hospital Taunton. He is one of the co-founders of EXTOD, a group that aims to provide evidence-based support for people with type 1 diabetes to undertake safe and effective exercise, and to enjoy its associated health benefits.

At the University he leads a group that researches how to encourage and support patients with diabetes to exercise. At Musgrove park hospital he runs specialist adult, adolescent and paediatric sports clinics to give advice to sports men, women and children who have Type 1 diabetes
James Byrne

Coming soon ..
Professor Shareen Forbes

Shareen Forbes is Professor of Diabetic Medicine at the University of Edinburgh, Lead Physician of the Islet Transplant Programme in Scotland and Visiting Professor of the Islet Transplant Programme, Edmonton, Canada. She graduated in Medicine from the University of Edinburgh and did specialist registrar training in diabetes, endocrinology and general medicine in London and was awarded her PhD Fellowship funded by the Novo Nordisk Foundation from Imperial College London. She was subsequently awarded a Diabetes UK Clinical Intermediate Fellowship examining metabolism in people with glucose intolerance.

The major focus in her research laboratory is of islet transplantation in rodent models including the underlying mechanisms limiting the success of the procedure. Working closely with researchers in the Scottish National Blood Transfusion Service, she has made important contributions in the field showing the efficacy of cell therapies including mesenchymal stromal cells when co-transplanted with islets in pre-clinical models. She also has an interest in stem cell derived islet transplantation and has a long- standing collaboration with Novo Nordisk stem cell therapy programme, Copenhagen, Denmark.

She is actively pursuing a number of these approaches at the clinical interface to improve long-term outcomes in people with Type 1 diabetes.
Forbes has expertise in medical statistics and her clinical research examines the clinical islet transplantation outcomes in collaboration with the UK Islet Transplant Consortium and the Edmonton Clinical Islet Transplant Programme. Working with Professor James Shaw and others in the UK Islet Transplant Consortium she found that a second transplant within 3 months of the first versus second transplants that were delayed, had better islet transplant outcomes (S Forbes, et al., Am J Tr 2022).

Patients in the UK are now prioritized on the waiting list to receive their second transplant within 3 months of their first. With Professor Peter Senior she developed and validated the BETA-2 score, a novel composite score of islet transplant function based on a fasting plasma sample and now adopted internationally (see app for calculation www.beta2score.com/). Further details of funding sources and grants: https://www.edinburghmetabolism.co.uk/shareen-forbes.
Dr. Jonathan Hazlehurst

Coming soon ..
Professor Tricia Tan

Coming soon ..

Management of hypoglycaemia post- bariatric surgery

Gold

Silver

Gold

Silver

Bronze

Management of hypoglycaemia post- bariatric surgery

Professor Rob Andrews

James Byrne

Professor Shareen Forbes

Dr. Jonathan Hazlehurst

Professor Tricia Tan

Search the Association of British Clinical Diabetologists